New Migraine Guidelines Offer Targeted Treatments, But Precision Remains a Challenge
Updated guidelines from the American Academy of Neurology and American Headache Society introduce CGRP-targeted drugs as first-line options for migraine prevention, offering new hope with high efficacy. However, choosing the optimal treatment for individual patients remains complex due to migraine's genetic heterogeneity and the need for personalized medicine.